{
  "type": "hyp",
  "text": "Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenesis and increase mouse spleen NK cell activity.\n",
  "self": {
    "NER": {
      "answers": [],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": []
      }
    },
    "NOUN": {
      "answers": [
        "Anti-transforming growth factor",
        "antibodies",
        "breast cancer cell tumorigenesis",
        "mouse spleen NK cell activity"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What type of antibodies inhibit breast cancer cell tumorigenesis?",
          "What inhibits breast cancer cell tumorigenesis?",
          "What do TGF-beta antibodies inhibit?",
          "What do anti-TGF-beta antibodies increase?"
        ]
      }
    }
  },
  "asked": {
    "What was the first step in the development of NK cells?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00523531436920166,
        "ground_truth": {
          "Intraperitoneal administration": {
            "bertscore": 0.6714496612548828,
            "f1": 0
          }
        }
      }
    },
    "What did intraperitoneal administration of 2G7 result in?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0005722641944885254,
        "ground_truth": {
          "a marked increase": {
            "bertscore": 0.7142496109008789,
            "f1": 0
          },
          "mouse spleen NK cell activity": {
            "bertscore": 0.6348184943199158,
            "f1": 0
          }
        }
      }
    }
  }
}